| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. | Director | Common Stock | 20,100 | $240,798 | $11.98 | 13 Jun 2024 | Direct |
| Neumora Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 80,000 | 28 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NMRA | Neumora Therapeutics, Inc. | 28 May 2025 | 5 | $0 | 4 | Director | 30 May 2025, 18:30 |
| NMRA | Neumora Therapeutics, Inc. | 13 Feb 2025 | 4 | $0 | 4 | Director | 18 Feb 2025, 16:30 |
| NMRA | Neumora Therapeutics, Inc. | 13 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 16:16 |
| NMRA | Neumora Therapeutics, Inc. | 14 Sep 2023 | 1 | $0 | 4 | Director | 18 Sep 2023, 17:56 |
| NMRA | Neumora Therapeutics, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Director | 14 Sep 2023, 19:06 |